Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis

Platelets

Volumn 10, Issue 5, 1999, Pages 285-292

  Amirkhosravi, Ali ^a   Amaya, Mildred ^a   Siddiqui, Farooq ^a   Biggerstaff, John P ^a   Meyer, Todd V ^a   Francis, John L ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

Experimental metastasis; GpIIb IIIa blockade; Tumor cell platelet adhesion; Vascular endothelial growth factor

Indexed keywords

ABCIXIMAB; FIBRINOGEN; FIBRINOGEN RECEPTOR; SEROTONIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; LEWIS CARCINOMA; MELANOMA CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTOPENIA; TUMOR CELL;

EID: 0032836245     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109975915     Document Type: Article

References (38)

1. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci USA 1968; 61: 46-52.
2. Gastpar H. Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approach to metastasis prophylaxis. J Med 1977; 8: 103-14.
3. Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973; 11: 704-18.
4. Zacharski LR, Moritz TE. Effect of RA-33 (mopidamole) on survival in carcinoma of the lung and colon Final report of VA cooperative study no. 188 (abstract). Thromb Haemost 1987; 58: 508.
5. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994; 121: 241-6.
6. Pearlstein E, Salk PL, Yogeeswaran G, Karpatkin S. Correlation between spontaneous metastasic potential and platelet-aggregating activity. Proc Natl Acad Sci USA 1980; 77: 4336-9.
7. Scarlett JD, Thurlow PJ, Connellan JM, Louis CJ. Plasma-dependent and - independent mechanisms of platelet aggregation induced by human tumour cell lines. Thromb Res 1987; 46: 715-26.
8. Grignani G, Pacchiarini L, Ricetti MM, Dionigi P, Jemos V, Zucchella M, Fratino P. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues. Invasion Metastasis 1989; 9: 298-309.
9. Mogi Y, Kogawa K, Takayama T, Yoshizaki N, Bannai K, Muramatsu H, Koike K, Kohgo Y, Watanabe N, Niitsu Y. Platelet aggregation induced by adenosine diphosphate released from cloned murine fibrosarcoma cells is positively correlated with the experimental metastatic potential of the cells. Jpn J Cancer Res 1991; 82: 192-8.
10. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229-36.
11. Nierodzik ML, Kajumo F, Karpatkin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 1992; 52: 3267-72.
12. Rao LVM. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev 1992; 11: 249-66.
13. Weiss L, Glaves D. Cancer cell damage at the vascular endothelium. Ann NY Acad Sci 1983; 416: 681-92.
14. Marcum JM, McGill M, Bastida E, Ordinas A, Jamieson GA. The interaction of platelets, tumor cells and vascular subendothelium. J Lab Clin Med 1980; 96: 1046-53.
15. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship. Cancer Metastasis Rev 1992; 11: 325-51.
16. Senger DR, Peruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986; 46: 5629-32.
17. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.
18. Anan K, Morisaki T, Katano M, Ikubo A, Kitsuki H, Uchiyama A, Kuroki S, Tanaka M, Torisu M. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 1996; 119: 333-9.
19. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/ vascular permeability factor 121. Cancer Res 1995; 55: 5296-301.
20. Claffey KP, Robinson GS. Regulation of VEGF/VPF expression in tumor cells: Consequences for tumor growth and metastasis. Cancer Metast Rev 1996; 15: 165-76.
21. Saleh M, Stacker SA, Wilks AF. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 1996; 56: 393-401.
22. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995; 95: 1789-97.
23. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham L, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77: 956-64.
24. Amirkhosravi A, Meyer T, Warnes G, Amaya M, Malik Z, Biggerstaff JP, Siddiqui FA, Sherman P, Francis JL. Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor. Thromb Haemost 1998; 80: 598-602.
25. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89: 11832-6.
26. Amirkhosravi M, Francis JL. Role of procoagulant activity in lung seeding of MC28 fibrosarcoma cells. Thromb Haemost 1993; 69: 602-602 (Abstract).
27. Edwards RL, Silver J, Rickles FR. Human tumor procoagulants: Registry of the Subcommittee of Haemostasis of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 205-13.
28. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3: 379-84.
29. Amirkhosravi M, Francis JL. Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo. Br J Haematol 1993; 85: 736-44.
30. Amirkhosravi M, Francis JE. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation. Thromb Haemost 1995; 73: 59-65.
31. Biggerstaff J, Amirkhosravi A, Francis JL. Three-dimensional visualization and quantitation of fibrin in solid tumors by confocal laser scanning microscopy. Cytometry 1997; 29: 122-7.
32. Honn KV, Onada JM, Mentor DG, et al. Platelet-tumor cell interactions as a target for antimetastatic therapy. In: Honn KV, Powers WE, Sloane BF, eds. Mechanisms of Cancer Metastasis. Boston: Martinus Nijhoff, 1986: 118-44.
33. Maloney WJ, Silliman CC, Ambruso DR, Wang J, Voelkerding KV. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol. 1998; 275: H1054-61
34. Coller BS. A new murine monoclonal antibody reports an activation dependent change in the conformation and/or micro-environment of the platelet glycoprotein IIb/IIIa complex. J Clin Invest 1985; 76: 101-8.
35. Biggerstaff JP, Seth NB, Meyer TV, Amirkhosravi M, Francis JL. Fibrin monomer increases platelet adherence to tumor cells in a flowing system: a possible role in metastasis. Thromb Res 1998; 92: S53-8.
36. Kadish JL, Wene KM, Dvorak HF. Tissue factor activity of normal and neoplastic cells: quantitation and species specificity. J Natl Cancer Inst 1983; 70: 551-7.
37. Revener JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: potential implications for the effect of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996; 98: 863-74.
38. v3 integrins. Circulation. 1998; 98: 1085-91.